FIELD: medicine.
SUBSTANCE: activity of enzymes MAO A and MAO B is determined in tumor tissue in menopausal and reproductive patients with uterine body cancer in stage III. If the coefficient value is 4.48 - 6.90 maintaining remission for at least 12 months after treatment termination is forecasted in treated patients, and if the coefficient value is 18.70 - 50.27 recurrence of disease minimally in 7 months is predicted.
EFFECT: use of the method enables to determine efficacy of integrated treatment of patients with uterine body cancer in menopause and reproductive periods.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING MALIGNANT AND BENIGN UTERINE PATHOLOGY | 2011 |
|
RU2484473C2 |
| METHOD OF PREDICTING DEVELOPMENT OF METACHRONOUS HYPERPLASTIC PROCESSES IN ORGANS OF FEMALE REPRODUCTIVE SYSTEM | 2010 |
|
RU2436517C1 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD OF ESTIMATING EFFICIENCY OF NEOADJUVANT AUTOHEMOCHEMOTHERAPY IN PATIENTS SUFFERING FROM CARCINOMA OF CERVIVAL STUMP | 2008 |
|
RU2375063C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE IN DISSEMINATED SKIN MELANOMA PATIENTS | 2008 |
|
RU2399057C1 |
| METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
| METHOD FOR PREDICTING RELAPSE DEVELOPMENT AT UTERINE BODY CANCER | 2002 |
|
RU2250077C2 |
| METHOD FOR PREDICTING EARLY RECURRENCE OF CLEAR CELL CARCINOMA OF THE UTERINE BODY | 2022 |
|
RU2784775C1 |
| METHOD OF PROVIDED EFFICIENCY OF NON-ADJUVANT AUTOHEMOCHEMOTHERAPY FOR PATIENTS SUFFERING FROM PAGET-TYPE BREAST CANCER | 2007 |
|
RU2328747C1 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN PATIETNS SUFFERING RECTAL CANCER | 2009 |
|
RU2420742C1 |
